Astria Therapeutics Inc. (ATXS)
NASDAQ: ATXS
· Real-Time Price · USD
6.85
0.09 (1.33%)
At close: Aug 15, 2025, 3:59 PM
6.85
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Astria Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 76.32M | 54.38M | 59.82M | 80.9M | 87.21M | 172.18M | 175.69M | 119.81M | 133.96M | 202.3M | 20.52M | 45.97M | 29.83M | 46.69M | 86.51M | 131.78M | 139.52M | 146.92M |
Short-Term Investments | 182.86M | 240.68M | 268.31M | 263.38M | 267.49M | 197.9M | 71M | 69M | 69M | 11.03M | 205.91M | 70.6M | 72.65M | 66.13M | 39M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39M | n/a | n/a | n/a |
Other Long-Term Assets | 8.79M | 2.59M | 2.61M | 4.39M | 4.38M | 4.08M | 3.36M | 1.88M | 1.98M | 1.99M | 3.25M | 245K | 190K | 204K | -38.95M | 50K | 176K | 182K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 9.41M | 7.9M | 6.51M | 7.58M | 3.19M | 163K | n/a | 2.66M | 1.46M | 2.12M | n/a | n/a | n/a | n/a | n/a | n/a | 532K | n/a |
Total Current Assets | 268.59M | 302.97M | 334.64M | 351.86M | 357.89M | 374.52M | 250.94M | 191.47M | 204.41M | 215.44M | 226.44M | 118.48M | 103.82M | 114.22M | 127.08M | 134.52M | 140.05M | 147.68M |
Property-Plant & Equipment | 4.55M | 4.83M | 5.11M | 5.39M | 5.71M | 210K | 363K | 514K | 661K | 806K | 948K | 1.09M | 1.28M | 228K | 394K | 557K | 717K | 874K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 13.34M | 7.42M | 7.72M | 9.78M | 10.1M | 4.29M | 3.72M | 2.4M | 2.64M | 2.79M | 4.2M | 1.33M | 1.47M | 432K | 439K | 607K | 893K | 1.06M |
Total Assets | 281.92M | 310.39M | 342.36M | 361.64M | 367.99M | 378.81M | 254.67M | 193.86M | 207.05M | 218.24M | 230.63M | 119.82M | 105.29M | 114.65M | 127.51M | 135.13M | 140.94M | 148.74M |
Account Payables | 738K | 3.69M | 4.32M | 1.28M | 2.34M | 862K | 1.51M | 1.14M | 829K | 930K | 788K | 790K | 995K | 931K | 1.56M | 574K | 619K | 1.81M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -578K | -573K | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.4M | n/a | n/a | n/a | n/a | 168K | 329K | 488K | 590K | n/a | n/a | 578K | 573K | 184K | n/a | 541K | 655K | 652K |
Other Current Liabilities | 15.91M | 1.94M | n/a | n/a | 10.24M | -168K | 5.33M | 4.6M | 2.85M | 974K | n/a | 2.39M | 1.68M | 2.96M | n/a | 1.53M | 1.04M | 589K |
Total Current Liabilities | 18.04M | 17.43M | 19.13M | 15.72M | 16.37M | 11.07M | 11.55M | 9.38M | 6.6M | 6.67M | 582K | 6.44M | 5.22M | 4.97M | 5.2M | 4.7M | 3.99M | 4.41M |
Long-Term Debt | 3.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 245.25M |
Total Long-Term Liabilities | 3.37M | 3.67M | 3.97M | 4.26M | 4.54M | n/a | n/a | n/a | 53K | 207K | 8.84M | 504K | 649K | 1.11M | 1.92M | n/a | 58K | 245.48M |
Total Liabilities | 21.41M | 21.1M | 23.1M | 19.98M | 20.91M | 11.07M | 11.55M | 9.38M | 6.65M | 6.88M | 9.42M | 6.95M | 5.87M | 4.97M | 5.2M | 4.7M | 4.05M | 249.88M |
Total Debt | 4.77M | 5.06M | 5.35M | 5.64M | 5.79M | 168K | 329K | 488K | 643K | 794K | 939K | 1.08M | 1.22M | 184K | 365K | 541K | 713K | 881K |
Common Stock | 57K | 57K | 57K | 57K | 55K | 55K | 41K | 28K | 28K | 28K | 28K | 16K | 13K | 13K | 13K | 13K | 77K | 23K |
Retained Earnings | -741.55M | -708.5M | -674.79M | -649.17M | -624.63M | -600.46M | -580.53M | -549.12M | -531.4M | -518.83M | -507.64M | -494.38M | -482.38M | -471.13M | -455.81M | -446.32M | -438.45M | -430.98M |
Comprehensive Income | -16K | 60K | 163K | 331K | -45K | -14K | -41K | n/a | -95.32M | -4K | -79K | -215K | -186K | -53K | -96.4M | n/a | n/a | -240.88M |
Shareholders Equity | 260.51M | 289.29M | 319.26M | 341.65M | 347.08M | 367.74M | 243.12M | 184.48M | 200.4M | 211.36M | 221.22M | 112.87M | 99.42M | 109.69M | 122.31M | 130.43M | 136.9M | -101.14M |
Total Investments | 182.86M | 240.68M | 268.31M | 263.38M | 267.49M | 197.9M | 71M | 69M | 69M | 11.03M | 205.91M | 70.6M | 72.65M | 66.13M | 39M | n/a | n/a | n/a |